KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Guardant Health (GH) Accumulated Depreciation & Amortization (2017 - 2025)

Guardant Health (GH) has disclosed Accumulated Depreciation & Amortization for 9 consecutive years, with $39.7 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 6.25% to $39.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.7 million through Dec 2025, down 6.25% year-over-year, with the annual reading at $39.7 million for FY2025, 6.25% down from the prior year.
  • Accumulated Depreciation & Amortization hit $39.7 million in Q4 2025 for Guardant Health, up from $29.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $42.9 million in Q4 2023 to a low of $5.0 million in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $22.6 million across 5 years, with a median of $21.2 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 61.47% in 2022 and later fell 7.04% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $22.3 million in 2021, then soared by 61.47% to $36.0 million in 2022, then rose by 19.24% to $42.9 million in 2023, then dropped by 1.15% to $42.4 million in 2024, then dropped by 6.25% to $39.7 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for GH at $39.7 million in Q4 2025, $29.7 million in Q3 2025, and $20.3 million in Q2 2025.